Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders.

NCT07133763 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

EBV-Associated Lymphoproliferative Disorders
PD-1 Inhibitor
Tenofovir
Chidamide
Lenalidomide

Interventions

DRUG: PD-1 Inhibitor Combined with Tenofovir, Chidamide, and Lenalidomide for the Treatment of EBV-Associated Lymphoproliferative Disorders.

Sponsor

The Affiliated Hospital of Xuzhou Medical University